ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 225 filers reported holding ALKERMES PLC in Q2 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $587,000 | -52.6% | 16,100 | -61.7% | 0.08% | -57.4% |
Q4 2018 | $1,239,000 | -44.3% | 41,989 | -19.9% | 0.19% | -11.7% |
Q3 2018 | $2,226,000 | -12.3% | 52,450 | -14.9% | 0.21% | -41.3% |
Q2 2018 | $2,538,000 | -33.9% | 61,650 | -6.9% | 0.36% | -32.5% |
Q1 2018 | $3,840,000 | +4.0% | 66,250 | -1.9% | 0.54% | -9.3% |
Q4 2017 | $3,694,000 | +0.9% | 67,500 | -6.2% | 0.59% | +12.5% |
Q3 2017 | $3,660,000 | -13.6% | 72,000 | -1.5% | 0.53% | -18.8% |
Q2 2017 | $4,238,000 | -0.8% | 73,100 | +0.1% | 0.65% | -0.8% |
Q1 2017 | $4,272,000 | +4.5% | 73,025 | -0.7% | 0.65% | -2.1% |
Q4 2016 | $4,087,000 | +14.6% | 73,535 | -3.0% | 0.67% | +23.2% |
Q3 2016 | $3,567,000 | +7.1% | 75,835 | -1.6% | 0.54% | +1.7% |
Q2 2016 | $3,331,000 | +25.3% | 77,060 | -0.9% | 0.53% | +139.0% |
Q1 2016 | $2,659,000 | -63.1% | 77,760 | -14.3% | 0.22% | -80.7% |
Q4 2015 | $7,205,000 | +36.4% | 90,760 | +0.8% | 1.16% | +38.7% |
Q3 2015 | $5,284,000 | +52.1% | 90,060 | +66.7% | 0.83% | +55.9% |
Q2 2015 | $3,475,000 | – | 54,010 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |